Clinical Trial Update: Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients [Phase 1]

View source ↗

Summary

This clinical trial update reports safety results from a multiple ascending-dose Phase 1 study of SAR113244 versus placebo in adult patients with systemic lupus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SAR113244

Snippet

Sponsor: Sanofi | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: COMPLETED